A bacterial ‘lipoprotein’ machine can be repurposed to build lipidated macrocyclic peptides

A 2026 PNAS paper reports a way to co-opt bacterial lipoprotein processing to biosynthesize lipidated macrocyclic peptides. It is a methods advance that could matter for lipopeptide discovery and tuning pharmacology.